DZ BANK AG DEUTSCHE ZENTRAL-GENOSSENSCHAFTSBANK, FRANKFURT AM MAIN DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main Share Price
Certificat
DE000DJ2X2W0
| Market Closed - Deutsche Boerse AG 01:04:23 06/07/2024 am IST | ||
| 102.6 EUR | -0.03% |
|
| Current month | -0.19% | ||
| 1 month | -1.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
APONTIS PHARMA AG
Latest news about APONTIS PHARMA AG
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 102.6 | -0.03% |
| 04/24/04 | 102.6 | -0.10% |
| 03/24/03 | 102.7 | -0.04% |
| 02/24/02 | 102.7 | -0.03% |
| 01/24/01 | 102.8 | -0.03% |
Delayed Quote Deutsche Boerse AG
Last update July 06, 2024 at 01:04 am IST
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | APONTIS PHARMA AG |
| Issuer | DZ BANK |
| WKN | DJ2X2W |
| ISIN | DE000DJ2X2W0 |
| Date issued | 05/10/2023 |
| Strike | 3 € |
| Maturity | 20/09/2024 (77 Days) |
| Parity | 0 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | both |
| Currency | EUR |
Technical Indicators
| Highest since issue | 107.1 € |
|---|---|
| Lowest since issue | 94.95 € |
Company Profile
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Sector
-
Consensus: Apontis Pharma AG
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.7
EUR
Average target price
17.38
EUR
Spread / Average Target
+99.71%
- Stock Market
- Certificates
- Certificat
